BioSpace News Archive

Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that it is nearing the previously-announced expiration date for its rights offering of 5:00 pm Eastern Time on March 1, 2023 (the “Expiration Date”).

TC BioPharm today announced the appointment of Dr. Michael Leek to the position of Chief Technology Officer.

Provention Bio, Inc. today announced that it will report its fourth quarter and full year 2022 financial results on Thursday, March 16, 2023, before the opening of the U.S. financial markets.

Biora Therapeutics, Inc., the biotech company that is reimagining therapeutic delivery, announced preliminary results from preclinical testing of its PGN-OB2 program, reporting an average bioavailability of 37% for semaglutide, a GLP-1 receptor agonist.

The College of American Pathologists is a professional organization that accredits clinical laboratories across the world. The CAP accreditation process is designed to ensure that laboratories meet or exceed the highest quality management system standards specific to patient testing.

Hoag Family Cancer Institute this week unveiled the newly expanded Patty & George Hoag Cancer Center in Newport Beach.

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conferences.

NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX) will report its financial results for the fourth quarter ended December 31, 2022 before market on Thursday, March 9, 2023.

Sinopia Biosciences, Inc. has been awarded a grant from the National Institute of Dental and Craniofacial Research, a branch of the U.S. National Institutes of Health, to fund the continued evaluation of therapeutic candidates to treat oral mucositis.

Bexion Pharmaceuticals, Inc. announced today results from their clinical trial entitled, “An open-label multi-center phase 1 safety study of BXQ-350 in children and young adults with relapsed solid tumors, including recurrent malignant brain tumors (KOURAGE)” have been published in the Volume 8, Issue 12, December, 2022, e12450 issue of Heliyon.